These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Genetic Effects of NDUFAF6 rs6982393 and APOE on Alzheimer's Disease in Chinese Rural Elderly: A Cross-Sectional Population-Based Study. Cheng Y; Li Y; Liang X; Wang P; Fa W; Liu C; Wang Y; Liu K; Wang N; Du Y Clin Interv Aging; 2022; 17():185-194. PubMed ID: 35237031 [TBL] [Abstract][Full Text] [Related]
24. Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier status. Malek-Ahmadi M; Beach T; Obradov A; Sue L; Belden C; Davis K; Walker DG; Lue L; Adem A; Sabbagh MN Curr Alzheimer Res; 2013 Jul; 10(6):654-9. PubMed ID: 23627755 [TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492 [TBL] [Abstract][Full Text] [Related]
26. APOE epsilon2 is associated with intact cognition but increased Alzheimer pathology in the oldest old. Berlau DJ; Corrada MM; Head E; Kawas CH Neurology; 2009 Mar; 72(9):829-34. PubMed ID: 19255410 [TBL] [Abstract][Full Text] [Related]
27. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study. Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117 [TBL] [Abstract][Full Text] [Related]
28. Primary age-related tauopathy in a Chinese cohort. Wang X; Zhang L; Lu H; Wu JL; Liang HZ; Liu C; Tao QQ; Wu ZY; Zhu KQ J Zhejiang Univ Sci B; 2020 Mar.; 21(3):256-262. PubMed ID: 32133802 [TBL] [Abstract][Full Text] [Related]
29. APOE epsilon4 does not predict mortality, cognitive decline, or dementia in the oldest old. Juva K; Verkkoniemi A; Viramo P; Polvikoski T; Kainulainen K; Kontula K; Sulkava R Neurology; 2000 Jan; 54(2):412-5. PubMed ID: 10668704 [TBL] [Abstract][Full Text] [Related]
30. Distribution and clinical impact of apolipoprotein E4 in subjective memory impairment and early mild cognitive impairment. Cho H; Kim YE; Chae W; Kim KW; Kim JW; Kim HJ; Na DL; Ki CS; Seo SW Sci Rep; 2020 Aug; 10(1):13365. PubMed ID: 32770103 [TBL] [Abstract][Full Text] [Related]
31. Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment. Insel PS; Hansson O; Mattsson-Carlgren N JAMA Neurol; 2021 Feb; 78(2):229-235. PubMed ID: 33044487 [TBL] [Abstract][Full Text] [Related]
32. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356 [TBL] [Abstract][Full Text] [Related]
33. Capillary amyloid-β protein deposition in a population-based study (Vantaa 85+). Mäkelä M; Paetau A; Polvikoski T; Myllykangas L; Tanskanen M J Alzheimers Dis; 2016; 49(1):149-57. PubMed ID: 26444758 [TBL] [Abstract][Full Text] [Related]
34. APOE and cerebral amyloid angiopathy in community-dwelling older persons. Yu L; Boyle PA; Nag S; Leurgans S; Buchman AS; Wilson RS; Arvanitakis Z; Farfel JM; De Jager PL; Bennett DA; Schneider JA Neurobiol Aging; 2015 Nov; 36(11):2946-2953. PubMed ID: 26341746 [TBL] [Abstract][Full Text] [Related]
35. Cognitive and Neuropsychological Profiles in Alzheimer's Disease and Primary Age-Related Tauopathy and the Influence of Comorbid Neuropathologies. Walker JM; Gonzales MM; Goette W; Farrell K; White Iii CL; Crary JF; Richardson TE J Alzheimers Dis; 2023; 92(3):1037-1049. PubMed ID: 36847012 [TBL] [Abstract][Full Text] [Related]
36. Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset. van der Vlies AE; Koedam EL; Pijnenburg YA; Twisk JW; Scheltens P; van der Flier WM Psychol Med; 2009 Nov; 39(11):1907-11. PubMed ID: 19335933 [TBL] [Abstract][Full Text] [Related]
37. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease. Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033 [TBL] [Abstract][Full Text] [Related]
38. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease. Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875 [TBL] [Abstract][Full Text] [Related]
39. Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis. Agarwal R; Tripathi CB Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):575-82. PubMed ID: 25551132 [TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population. Yip AG; Brayne C; Easton D; Rubinsztein DC; J Med Genet; 2002 Sep; 39(9):639-43. PubMed ID: 12205106 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]